Abstract: Currently, the analysis of metals for toxicity evaluation are only assayed for total quantity/quantitative elemental analysis, and no assessment to date evaluates the individual toxicities and sum total toxicities of the individual chemical forms of metals, which can be radically different. A better assessment of true toxicity can be made by looking at the quantitative numbers of each of the chemical forms the metal exists in as a function of one of the different valuations of toxicity, such as LD50 numbers, LD0, LD100, LC50, LOAEL, NOAEL, PEL, REL, TLV, etc., for a new terminology of Toxic Relevance Number (TRN), and the sum of TRN's for the individual chemical forms as TTRN, Total Toxic Relevance Number. While LD 50 is preferred, any of these valuations can be used in the same model to advance our understanding and assessment of true toxicity of a certain metal in a specific exposure.

Abstract: A nutritional supplement for the prevention and treatment of excessive intestinal permeability is provided. The treatment includes a dietary regimen of nutritional buffers, amino acid chelates, minerals and vitamins. Other components may include antioxidants, free radical scavengers, beneficial organisms, and intestinal tract-soothing herbs.

Abstract: A nutritional supplement for the prevention and treatment of excessive intestinal permeability is provided. The treatment includes a dietary regimen of nutritional buffers, amino acid chelates, minerals and vitamins. Other components may include antioxidants, free radical scavengers, beneficial organisms, and intestinal tract-soothing herbs.

Abstract: Therapeutic bath salts for the relaxation of muscles, elimination or reduction of muscle spasms, and for the overall enhancement of a person's mood. The bath salts of the present invention are used as aromatherapy that has both the convenience of a bath and the internal mechanisms of ingested medication. The formula for the composition of the present invention includes a selected amount of magnesium sulfate trihydrate (a hydrated version of epsom salts), lithium chloride, copper gluconate, and essential oils. The oils include rosewood oil, ylang ylang oil, lavender oil and patchouli oil. The oils are provided as scents for use in the prescribed aromatherapy. The user mixes a preselected amount of the crystallized salt or liquid form of the present invention with the bath water. A period of time is allowed to elapse before the user departs the bath. By resting in the tub, the user accrues the combined benefits of external therapy and internal therapy.

Abstract: A pharmaceutical composition having buffering properties comprises as its primary ingredients calcium carbonate (CaCO.sub.3) and magnesium oxide (MgO; magnesia) that form the base for the compound. Potassium sorbate (CH.sub.3 CH: CHCH:CHCOOK) is provided as a preservative. Other ingredients include a tabletizing binder, vitamin complexes, minerals as antipathogens, and flavorings.

Abstract: A dietary system for the treatment of obesity, for the lowering of saturated fats in the blood and, in a modified form, for stimulation of the sympathetic nervous system and general basal metabolism. The system includes a diet that restricts the patient to the intake of certain foods in certain amounts and combines this intake with specific supplements. The supplements include prescribed amounts of vitamins, minerals, and oils. The oils are selected from that group that are high in essential fatty acids such as olive oil and canola oil. The prescribed foods comprise low fat, low carbohydrate, moderate protein foods. By providing the patient with a diet high in essential fatty acids, the glucagon-driven pathway of the patient is stimulated and less fat is stored by the body. In addition, more body fat is catalyzed for the production of energy for use by the body. In its modified form, the diet includes a daily regimen of various hormones including DHEA, progesterone, testosterone, and desiccated thyroid.

Abstract: A liquid pharmaceutical composition having buffering properties comprises as its primary ingredients calcium carbonate (CaCO.sub.3) and magnesium oxide (MgO; magnesia) or magnesium hydroxide (Mg(OH).sub.2) that form the base for the compound. The base is carried in a suspension of oil and water. Lecithin (CH.sub.2 (R)CH(R')CH.sub.2 OPO(OH))(CH.sub.2).sub.2 N(OH)(CH.sub.2).sub.3 is provided as an emulsifier and potassium sorbate (CH.sub.3 CH: CHCH:CHCOOK) is provided as a preservative. Other ingredients include vitamin complexes, selected metal chelates as antipathogens, and flavorings.

Abstract: A dietary system for the treatment of obesity and for the lowering of saturated fats in the blood. The system includes a diet that restricts the patient to the intake of certain foods in certain amounts and combines this intake with specific supplements. The prescribed foods comprise those low in saturated fats and carbohydrates, those having moderate amounts of proteins, and oils high in monounsaturates and certain fatty acids such as olive oil and canola oil. The supplements include prescribed amounts of vitamins and minerals. By providing the patient with a diet high in essential fatty acids, the glucagon-driven pathway of the patient is stimulated and less fat is stored by the body. In addition, more body fat is catalyzed for the production of energy for use by the body.